Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19.

Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19.

Publication date: Mar 16, 2024

Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide and caused mortality. Many factors have been reported to affect the prognosis of COVID-19. In this study, we aimed to investigate the effects of drug therapy and vaccination on prognosis in patients hospitalized with a COVID-19 diagnosis. In this single-center, cross-sectional study, data were retrospectively collected from patients receiving inpatient treatment at a university hospital with a diagnosis of COVID-19 between January 1, 2020, and April 30, 2022. The patients’ demographic and clinical characteristics were recorded. The Chi-square, Cox and logistic regression was performed, Pā€‰ā€‰3 doses: 45. 7%). Mortality rate was 17. 0%. Increasing age, male, a high Charlson Comorbidity Index (CCI), and no vaccination significantly increased mortality (Pā€‰

Concepts Keywords
Coronavirus Chloroquine
Covid COVID
Cox Elderly
Inpatient Favipiravir
Prognosis
Vaccine

Semantics

Type Source Name
disease VO vaccination
disease MESH COVID-19
disease MESH Comorbidity
disease MESH Long Covid
drug DRUGBANK Chloroquine
drug DRUGBANK Favipiravir
disease VO vaccine

Original Article

(Visited 1 times, 1 visits today)